Doxorubicin-Induced Cardiomyopathy Overview
Learn About Doxorubicin-Induced Cardiomyopathy
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
CVI - Cardiovascular Clinic
Aarti Asnani is an Internal Medicine provider in Boston, Massachusetts. Dr. Asnani has been practicing medicine for over 18 years and is rated as an Elite provider by MediFind in the treatment of Doxorubicin-Induced Cardiomyopathy. Her top areas of expertise are Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Myocarditis, Cardiomyopathy, and Pacemaker Implantation.
Steven Lipshultz is a Pediatric Cardiologist in Buffalo, New York. Dr. Lipshultz is rated as an Elite provider by MediFind in the treatment of Doxorubicin-Induced Cardiomyopathy. His top areas of expertise are Cardiomyopathy, Dilated Cardiomyopathy (DCM), Cardiomyopathy Due to Anthracyclines, Heart Transplant, and Gastric Bypass.
Ballad Health CVA Heart Institute
. Dr. Fernandez is rated as an Advanced provider by MediFind in the treatment of Doxorubicin-Induced Cardiomyopathy. His top areas of expertise are Familial Neurocardiogenic Syncope, Apoplexy, Aortic Regurgitation, and Cardiomyopathy.
Summary: Patients treated for DLBCL are at high risk of developing AICD. This adverse event is characterized by irreversible damage to the heart muscle with a loss of cardiomyocytes and subsequent decline in cardiac pumping capacity. Thereby patients treated for this malignancy are at double the risk of developing symptomatic heart failure / cardiomyopathy when compared to the general population. This corr...


